// App-Quantinova.ai

: Dupilumab treatment restores skin barrier function and improves clinical and patient reported outcomes in adults and adolescents with moderate to severe atopic dermatitis

Researchers

Presenter

  • Robert Bissonnette

Principal Investigators

  • Donald Y.M. Leung

  • Gabriel Bologna

  • Noah A. Levit

  • Ana B. Rossi

  • Annie Zhang

Medical Centers

  • National Jewish Health, Denver, Colorado, USA

  • Sanofi Genzyme, Cambridge, USA

  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

Disease

  • Atopic Dermatitis

Biomarkers

  • Transepidermal water loss

Drug/Treatment

  • Dupilumab

Outcome

  • N/A

Study Design

  • Open Label

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved